Literature DB >> 17307986

Role of acidic pH in the susceptibility of intraphagocytic methicillin-resistant Staphylococcus aureus strains to meropenem and cloxacillin.

Sandrine Lemaire1, Françoise Van Bambeke, Marie-Paule Mingeot-Leclercq, Youri Glupczynski, Paul M Tulkens.   

Abstract

Early studies showed that methicillin-resistant Staphylococcus aureus (MRSA) strains are susceptible to beta-lactams when they are exposed to pH < or = 5.5 in broth. Because S. aureus survives in the phagolysosomes of macrophages, where the pH may be acidic, we have examined the susceptibility of MRSA ATCC 33591 phagocytized by human THP-1 macrophages to meropenem (MEM) and cloxacillin (CLX). Using a pharmacodynamic model assessing key pharmacological (50% effective concentration and maximal efficacy) and microbiological (static concentration) descriptors of antibiotic activity, we show that intraphagocytic MRSA strains are as sensitive to MEM and CLX as methicillin-susceptible S. aureus (MSSA; ATCC 25923). This observation was replicated in broth if the pH was brought to 5.5 and was confirmed with clinical strains. Electron microscopy showed that both the MRSA and the MSSA strains localized and multiplied in membrane-bounded structures (phagolysosomes) in the absence of beta-lactams. Incubation of the infected macrophages with ammonium chloride (to raise the phagolysosomal pH) made MRSA insensitive to MEM and CLX. No difference was seen in mec, mecA, mecI, mecR1, femA, and femB expression (reversed transcription-PCR) or in PBP 2a content (immunodetection) in MRSA grown in broth at pH 5.5 compared with that in MRSA grown in broth at 7.4. The level of [(14)C]benzylpenicillin binding to cell walls prepared from a non-beta-lactamase-producing MRSA clinical isolate was two times lower than that to cell walls prepared from MSSA ATCC 25923 at pH 7.4, but the levels increased to similar values for both strains at pH 5.5. These data suggest that the restoration of susceptibility of intraphagocytic of MRSA to MEM and CLX is due to the acidic pH prevailing in phagolysosomes and is mediated by an enhanced binding to penicillin-binding proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17307986      PMCID: PMC1855560          DOI: 10.1128/AAC.01192-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

Review 1.  Is Staphylococcus aureus an intracellular pathogen?

Authors:  F D Lowy
Journal:  Trends Microbiol       Date:  2000-08       Impact factor: 17.079

2.  Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents.

Authors:  S Ohkuma; B Poole
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

3.  Suppression of intrinsic resistance to methicillin and other penicillins in Staphylococcus aureus.

Authors:  L D Sabath; S J Wallace; D A Gerstein
Journal:  Antimicrob Agents Chemother       Date:  1972-11       Impact factor: 5.191

4.  Multiplex PCR for simultaneous identification of Staphylococcus aureus and detection of methicillin and mupirocin resistance.

Authors:  E Pérez-Roth; F Claverie-Martín; J Villar; S Méndez-Alvarez
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus.

Authors:  B J Hartman; A Tomasz
Journal:  J Bacteriol       Date:  1984-05       Impact factor: 3.490

6.  Mechanistic basis for the action of new cephalosporin antibiotics effective against methicillin- and vancomycin-resistant Staphylococcus aureus.

Authors:  Cosimo Fuda; Dusan Hesek; Mijoon Lee; Werner Heilmayer; Rodger Novak; Sergei B Vakulenko; Shahriar Mobashery
Journal:  J Biol Chem       Date:  2006-02-03       Impact factor: 5.157

7.  An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci.

Authors:  M G Pinho; H de Lencastre; A Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

8.  The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.

Authors:  Cosimo Fuda; Maxim Suvorov; Sergei B Vakulenko; Shahriar Mobashery
Journal:  J Biol Chem       Date:  2004-06-28       Impact factor: 5.157

9.  Local variants of Staphylococcal cassette chromosome mec in sporadic methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococci: evidence of horizontal gene transfer?

Authors:  Anne-Merethe Hanssen; Gry Kjeldsen; Johanna U Ericson Sollid
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

10.  Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages.

Authors:  B Poole; S Ohkuma
Journal:  J Cell Biol       Date:  1981-09       Impact factor: 10.539

View more
  10 in total

1.  Activity of a novel protonophore against methicillin-resistant Staphylococcus aureus.

Authors:  Nagendran Tharmalingam; Elamparithi Jayamani; Rajmohan Rajamuthiah; Dawilmer Castillo; Beth Burgwyn Fuchs; Michael J Kelso; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2017-08-03       Impact factor: 3.808

2.  Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Enterobacteriaceae.

Authors:  Maria Loose; Isabell Link; Kurt G Naber; Florian M E Wagenlehner
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

3.  Cellular pharmacokinetics and intracellular activity of the novel peptide deformylase inhibitor GSK1322322 against Staphylococcus aureus laboratory and clinical strains with various resistance phenotypes: studies with human THP-1 monocytes and J774 murine macrophages.

Authors:  Frédéric Peyrusson; Deborah Butler; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

4.  Antimicrobial activity against intraosteoblastic Staphylococcus aureus.

Authors:  Florent Valour; Sophie Trouillet-Assant; Natacha Riffard; Jason Tasse; Sacha Flammier; Jean-Philippe Rasigade; Christian Chidiac; François Vandenesch; Tristan Ferry; Frédéric Laurent
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

5.  Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

Authors:  Sandrine Lemaire; Youri Glupczynski; Valérie Duval; Bernard Joris; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

6.  Restoration of susceptibility of methicillin-resistant Staphylococcus aureus to beta-lactam antibiotics by acidic pH: role of penicillin-binding protein PBP 2a.

Authors:  Sandrine Lemaire; Cosimo Fuda; Françoise Van Bambeke; Paul M Tulkens; Shahriar Mobashery
Journal:  J Biol Chem       Date:  2008-03-12       Impact factor: 5.157

7.  Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.

Authors:  Sandrine Lemaire; Aurélie Olivier; Françoise Van Bambeke; Paul M Tulkens; Peter C Appelbaum; Youri Glupczynski
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

8.  Defining the microbial effluxome in the content of the host-microbiome interaction.

Authors:  Anastasios Ioannidis; Maria Magana; Cristian G Bologa; Tudor I Oprea; Ian T Paulsen; George P Tegos
Journal:  Front Pharmacol       Date:  2015-02-19       Impact factor: 5.810

Review 9.  In vitro antibiotic activity against intraosteoblastic Staphylococcus aureus: a narrative review of the literature.

Authors:  Florian C Marro; Lélia Abad; Ariel J Blocker; Frédéric Laurent; Jérôme Josse; Florent Valour
Journal:  J Antimicrob Chemother       Date:  2021-11-12       Impact factor: 5.790

10.  Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori.

Authors:  Nagendran Tharmalingam; Jenna Port; Dawilmer Castillo; Eleftherios Mylonakis
Journal:  Sci Rep       Date:  2018-02-27       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.